A. Sabbatini

1.1k total citations
32 papers, 688 citations indexed

About

A. Sabbatini is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, A. Sabbatini has authored 32 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Epidemiology. Recurrent topics in A. Sabbatini's work include Blood Pressure and Hypertension Studies (14 papers), Cardiovascular Health and Disease Prevention (10 papers) and Hormonal Regulation and Hypertension (5 papers). A. Sabbatini is often cited by papers focused on Blood Pressure and Hypertension Studies (14 papers), Cardiovascular Health and Disease Prevention (10 papers) and Hormonal Regulation and Hypertension (5 papers). A. Sabbatini collaborates with scholars based in Brazil, United States and United Kingdom. A. Sabbatini's co-authors include Georgios Kararigas, Heitor Moreno, Ana Paula de Faria, Natália R. Barbaro, Vanessa Fontana, Rodrigo Modolo, Alessandra Mileni Versuti Ritter, Stéphane Laurent, Francisco Antônio Helfenstein Fonseca and Caroline Demacq and has published in prestigious journals such as Journal of the American College of Cardiology, British Journal of Pharmacology and Gene.

In The Last Decade

A. Sabbatini

32 papers receiving 678 citations

Peers

A. Sabbatini
A. Sabbatini
Citations per year, relative to A. Sabbatini A. Sabbatini (= 1×) peers Ana Paula de Faria

Countries citing papers authored by A. Sabbatini

Since Specialization
Citations

This map shows the geographic impact of A. Sabbatini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Sabbatini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Sabbatini more than expected).

Fields of papers citing papers by A. Sabbatini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Sabbatini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Sabbatini. The network helps show where A. Sabbatini may publish in the future.

Co-authorship network of co-authors of A. Sabbatini

This figure shows the co-authorship network connecting the top 25 collaborators of A. Sabbatini. A scholar is included among the top collaborators of A. Sabbatini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Sabbatini. A. Sabbatini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabbatini, A. & Georgios Kararigas. (2020). Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF. Journal of the American College of Cardiology. 75(9). 1074–1082. 96 indexed citations
2.
Sabbatini, A. & Georgios Kararigas. (2020). Estrogen-related mechanisms in sex differences of hypertension and target organ damage. Biology of Sex Differences. 11(1). 31–31. 96 indexed citations
3.
March, J E, A. Sabbatini, Stephen J. Hill, et al.. (2019). The effect of two selective A1‐receptor agonists and the bitopic ligand VCP746 on heart rate and regional vascular conductance in conscious rats. British Journal of Pharmacology. 177(2). 346–359. 4 indexed citations
4.
Modolo, Rodrigo, Alessandra Mileni Versuti Ritter, A. Sabbatini, et al.. (2018). Metabolic Syndrome-Related Features in Controlled and Resistant Hypertensive Subjects. Arquivos Brasileiros de Cardiologia. 110(6). 514–521. 14 indexed citations
5.
Ritter, Alessandra Mileni Versuti, Ana Paula de Faria, A. Sabbatini, et al.. (2017). MCP-1 Levels are Associated with Cardiac Remodeling but not with Resistant Hypertension. Arquivos Brasileiros de Cardiologia. 108(4). 331–338. 10 indexed citations
6.
Ritter, Alessandra Mileni Versuti, Ana Paula de Faria, Natália R. Barbaro, et al.. (2017). The rs243866/243865 polymorphisms in MMP-2 gene and the relationship with BP control in obese resistant hypertensive subjects. Gene. 646. 129–135. 8 indexed citations
7.
Sabbatini, A., et al.. (2016). [PP.10.24] EFFECTS OF TNF-ALPHA INHIBITON ON HEMODYNAMIC PARAMETERS AND BIOMARKERS IN RESISTANT HYPERTENSION. Journal of Hypertension. 34(Supplement 2). e176–e176. 2 indexed citations
8.
Sabbatini, A., Natália R. Barbaro, Ana Paula de Faria, et al.. (2016). Increased Circulating Tissue Inhibitor of Metalloproteinase‐2 Is Associated With Resistant Hypertension. Journal of Clinical Hypertension. 18(10). 969–975. 8 indexed citations
9.
Modolo, Rodrigo, Ana Paula de Faria, A. Sabbatini, et al.. (2015). Refractory and resistant hypertension: characteristics and differences observed in a specialized clinic. Journal of the American Society of Hypertension. 9(5). 397–402. 32 indexed citations
10.
Ritter, Alessandra Mileni Versuti, Vanessa Fontana, Ana Paula de Faria, et al.. (2015). Association of Mineralocorticoid Receptor Polymorphism I180V With Left Ventricular Hypertrophy in Resistant Hypertension. American Journal of Hypertension. 29(2). 245–250. 11 indexed citations
11.
Faria, Ana Paula de, Vanessa Fontana, Rodrigo Modolo, et al.. (2014). Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension. Clinica Chimica Acta. 433. 179–183. 27 indexed citations
12.
Sabbatini, A., Vanessa Fontana, Stéphane Laurent, & Heitor Moreno. (2014). An update on the role of adipokines in arterial stiffness and hypertension. Journal of Hypertension. 33(3). 435–444. 41 indexed citations
13.
Faria, Ana Paula de, María Ondina Paganelli, A. Sabbatini, et al.. (2014). Predictors of Silent Myocardial Ischemia in Resistant Hypertensive Patients. American Journal of Hypertension. 28(2). 200–207. 6 indexed citations
14.
Modolo, Rodrigo, Natália R. Barbaro, Ana Paula de Faria, et al.. (2014). The white-coat effect is an independent predictor of myocardial ischemia in resistant hypertension. Blood Pressure. 23(5). 276–280. 15 indexed citations
15.
Fontana, Vanessa, Ana Paula de Faria, Natália R. Barbaro, et al.. (2013). Modulation of aldosterone levels by −344 C/T CYP11B2 polymorphism and spironolactone use in resistant hypertension. Journal of the American Society of Hypertension. 8(3). 146–151. 14 indexed citations
16.
Faria, Ana Paula de, et al.. (2013). Phenotypic Characteristics of Resistant Hypertension in the Brazilian Population. Arquivos Brasileiros de Cardiologia. 100(6). 579–82. 4 indexed citations
17.
Demacq, Caroline, Valéria Nasser Figueiredo, A. Sabbatini, et al.. (2013). Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension. Hypertension Research. 36(12). 1067–1072. 37 indexed citations
18.
Sabbatini, A., Ana Paula de Faria, Natália R. Barbaro, et al.. (2013). Deregulation of adipokines related to target organ damage on resistant hypertension. Journal of Human Hypertension. 28(6). 388–392. 37 indexed citations
19.
Quinaglia, Thiago, Ana Paula de Faria, Vanessa Fontana, et al.. (2013). Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension. European Journal of Clinical Pharmacology. 69(12). 2027–2036. 11 indexed citations
20.
Figueiredo, Valéria Nasser, Ana Paula de Faria, Natália R. Barbaro, et al.. (2012). High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension. Journal of Human Hypertension. 27(4). 225–230. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026